DAPSONE 6% / NIACINAMIDE 4%- dapsone 6% / niacinamide 4% gel 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DAPSONE 6% / NIACINAMIDE 4%

Directions for use

g

Sincerus Florida, LLC adverse reactions.

d

Active, inactive

d

NDC 72934-1063-2
DAPSONE 6 / NIACINAMIDE 4
Gel 30gm

f

DAPSONE 6% / NIACINAMIDE 4% 
dapsone 6% / niacinamide 4% gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1063
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) DAPSONE6 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-1063-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/01/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-1063)

Revised: 4/2019
Document Id: 8738e2b0-0b52-3a26-e053-2991aa0a1ade
Set id: 8738e2b0-0b51-3a26-e053-2991aa0a1ade
Version: 1
Effective Time: 20190423
 
Sincerus Florida, LLC